• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2023 Aug 14;29(9).
doi: 10.3201/eid2909.230417. Online ahead of print.
Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population

Liana R Andronescu, Stephanie A Richard, Eric D Laing, Nora Pisanic, Si'Ana A Coggins, Magdielis Gregory Rivera, Kate Kruczynski, Adam K Saperstein, Jitendrakumar Modi, Jamie A Fraser, Saira Shaikh, Christopher C Broder, Timothy H Burgess, Christopher D Heaney, Simon D Pollett, Eugene Millar, Christian L Coles, Mark P Simons
Abstract

The optimal approach to COVID-19 surveillance in congregate populations remains unclear. Our study at the US Naval Academy in Annapolis, Maryland, USA, assessed the concordance of antibody prevalence in longitudinally collected dried blood spots and saliva in a setting of frequent PCR-based testing. Our findings highlight the utility of salivary-based surveillance.

Keywords: COVID-19; SARS-CoV-2; congregate population; coronavirus disease; dried blood spot; respiratory infections; saliva; severe acute respiratory syndrome coronavirus 2; strategies; surveillance; vaccine-preventable diseases; viruses; zoonoses.

 
Back
Top Bottom